Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

14 Jun 2024 12:30

RNS Number : 5420S
British Smaller Companies VCT2 Plc
14 June 2024
 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 31 March 2024

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 31 March 2024. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

 

Overview

In the quarter to 31 March 2024, the Company saw a 0.1 per cent reduction in its Net Asset Value per share to 59.25 pence, compared to a 0.6 per cent fall in the FTSE Small Cap.

The Company's Total Return at 31 March 2024 was down 0.05 pence at 145.50 pence per ordinary share.

During the quarter, the Company invested £1.2 million into three existing portfolio companies: Outpost, Relative Insight and SharpCloud. Subsequent to the period-end, £3.1 million has been invested into two new investments, Fuuse and Ohalo.

The Company has had a busy quarter of exit activity; it partially realised its investments in KeTech and Arcus in January 2024, and fully exited its investment in Displayplan in February 2024.

The Company realisation of Displayplan generated proceeds of £4.8 million. Total proceeds received over the life of the investment are £6.7 million, an excellent 9.6x return on the Company's cost. There is the potential for further receipts in due course, with £0.4 million of deferred proceeds recognised at the period end.

The KeTech business was split into its two component parts, Rail and Defence, to maximise shareholder value, with the Defence business subsequently sold in January 2024, generating proceeds of £1.5 million. To date, the Company has realised proceeds of £4.1 million from its KeTech investment, a 2.0x return on cost, while still retaining its investment in the Rail business, which at the period-end was valued at £1.2 million.

The Company realised part of its investment in Arcus, generating proceeds of £0.2 million, while still retaining its investment in the remaining restructured business, which at the period-end was valued at £0.6 million.

The Company, alongside British Smaller Companies VCT plc, raised £90 million in aggregate under the Offers launched on 20 September 2023 in relation to the 2023/24 tax year. A total of £34.5 million was raised by the Company, of which £11.4 million was allotted on 30 January 2024 and £23.1 million was allotted shortly after the period-end, on 3 April 2024.

Performance

The movement in Total Return in pence per ordinary share is set out in the table below:

 

 

31 December 2023

Increase in value

Issue/Buy-back of shares

Movement

in period

31 March 2024

Net Assets (£m)

135.6

0.3

10.4

10.7

146.3

NAV per share (PPS)

59.30p

0.15p

(0.20p)

(0.05p)

59.25p

Cumulative dividends paid (PPS)

86.25p

-

-

-

86.25p

Total Return (PPS)

145.55p

0.15p

(0.20p)

(0.05p)

145.50p

Shares in issue

228,758,665

-

18,214,394

18,214,394

246,973,059

 

The movements in NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 31 December 2023

135.6

59.30

Increase in portfolio value

0.4

0.15

Net operating costs

(0.1)

-

0.3

0.15

Issue/buy-back of shares*

10.4

(0.20)

Total Return in the period

10.7

(0.05)

NAV at 31 March 2024

 

146.3

 

59.25

 

* The allotment of shares from the first allotment of the 2023/24 fundraising reduced Total Return per ordinary share as the fundraising was priced at the last reported NAV at the time of the allotment of 56.90 pence per ordinary share, being the NAV as at 30 September 2023 of 58.40 pence per ordinary share, adjusted for the interim dividend of 1.50 pence per ordinary share paid on 3 November 2023.

Buy-backs and shares in issue

On 30 January 2024 the Company issued 19,533,372 shares at prices between 57.76 pence and 60.83 pence per share in the first allotment relating to the 2023/34 fundraising.

On 25 March 2024, the Company purchased 1,318,978 ordinary shares of 10 pence each at a price of 56.84 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 31 March 2024 was 246,973,059 (31 December 2023: 228,758,665), with a further 22,702,746 ordinary shares held in treasury (31 December 2023: 21,383,768).

Subsequent to the quarter end, on 3 April 2024 the Company issued 37,666,087 shares at prices between 59.76 pence and 63.95 pence per share in the second and final allotment relating to the 2023/34 fundraising, taking the number of shares in issue at that date to 284,639,146, with a further 22,702,746 shares held in treasury.

Net assets

Net assets at 31 March 2024 comprised the following:

£000

% of net assets

Unquoted investments at fair value

91,163

62.3

Cash and cash equivalents

54,682

37.4

Other net current assets

454

0.3

Net assets

146,299

100.0

 

Investments

The investment portfolio at 31 March 2024 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion

23,158

15.8%

Unbiased

8,554

21.7%

Outpost

6,346

26.0%

Elucidat

3,954

28.7%

Force24

3,890

31.4%

SharpCloud

3,584

33.8%

Vypr

3,544

36.2%

ACC Aviation

3,163

38.4%

Wooshii

2,767

40.3%

Quality Clouds

2,679

42.1%

61,639

42.1%

Other investments

29,524

62.3%

Total investments

91,163

62.3%

 

New director and Chair

On 13 June 2024, at the end of the Company's AGM, Peter Waller retired as Chair and stood down from the Board. The Board and the Manager thank Peter for all of his efforts and valuable contributions over the course of his tenure. Barbara Anderson, who has served as a director of the Company for three years, succeeds Peter as Chair.

Also on 13 June 2024, Arif Ahmed joined the Board of Directors. Arif is a serial entrepreneur and private equity investor with particular expertise in healthcare and technology.

Shareholder relations

The Company will be hosting a physical investor workshop jointly with British Smaller Companies VCT plc on 20 June 2024 at One Great George Street, Westminster, London SW1 3AA to provide an update to shareholders; for further details please contact Tracey Nice at tracey.nice@yfmep.com.

Outlook

Despite recent declines in inflation rates, central banks remain cautious, with interest rates remaining at elevated levels for longer than originally anticipated. 2024 has the potential for further geopolitical instability, with elections taking place across a significant proportion of the globe and ongoing conflicts in Ukraine and the Middle East.

Portfolio companies continue to demonstrate resilience in their trading and navigation of this environment. Last year's priority of capital efficiency has left companies well positioned for growth, with multiple opportunities for the Company to deploy capital anticipated over the next six to 12 months. The Company's successful 2023/24 fundraising provides the capital to support this strategy, as well as continuing to invest in exciting new opportunities.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

14 June 2024

For further information please contact:

Dan Perkins YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFGPUMUQUPCGGC
Date   Source Headline
18th Dec 201410:00 amRNSCompletion of New Investment
8th Dec 20141:07 pmRNSTransaction in Own Shares
3rd Dec 201412:54 pmRNSResult of General Meeting
3rd Dec 20149:23 amRNSCompletion of New Investments
20th Nov 201410:57 amRNSInterim Statement & Change of Company Secretary
27th Oct 20144:40 pmRNSCompletion of two new investments
20th Oct 20145:00 pmRNSPublication of Prospectus and Circular re: offers
10th Oct 201412:43 pmRNSDirector Declaration
7th Oct 20145:10 pmRNSPayment of Dividend and Allotment of Share
15th Aug 201411:47 amRNSHalf Yearly Report
18th Jul 201411:27 amRNSIssue of Equity - Replacement
30th Jun 20144:16 pmRNSIssue of Equity
27th Jun 20144:36 pmRNSTransaction in Own Shares
30th May 20147:00 amRNSOffers for Subscription: Allotment of Shares
28th May 20144:46 pmRNSDividend Payment Date
19th May 20142:21 pmRNSInterim Management Statement to 31 March 2014
19th May 201412:52 pmRNSResult of Annual General Meeting
29th Apr 20147:00 amRNSPostponement of Allotment and Dividend
10th Apr 20145:50 pmRNSJoint Offers - Supplementary Prospectus
7th Apr 201410:15 amRNSOffers for Subscription: Allotment of Shares
7th Apr 201410:15 amRNSOffers for Subscription: Allotment of Shares
7th Apr 20147:00 amRNSOffers for Subscription: Allotment of Shares
7th Apr 20147:00 amRNSOffers for Subscription: Allotment of Shares
1st Apr 20145:25 pmRNSOffers for Subscription: Allotment of Shares
28th Mar 20144:13 pmRNSAnnual Financial Report
18th Feb 20145:30 pmRNSResult of General Meeting
15th Jan 20147:30 amRNSPublication of Prospectus re: joint offer
31st Oct 20137:15 amRNSTransaction in Own Shares
25th Oct 20137:00 amRNSInterim Management Statement to 30 September 2013
30th Sep 20135:30 pmRNSManagement Arrangements
27th Sep 201311:02 amRNSIssue of Equity and Dividend Paid
23rd Sep 20135:17 pmRNSStatement re Proposed Joint Fundraising
21st Aug 20131:48 pmRNSHalf Yearly Report to 30 June 2013
19th Jun 20134:34 pmRNSTransaction in Own Shares
5th Jun 201311:04 amRNSIssue of Equity
20th May 20131:35 pmRNSResult of AGM
1st May 20137:00 amRNSIssue of Equity
30th Apr 201312:24 pmRNS1st Quarter - Interim Management Statement
19th Apr 20137:00 amRNSTransaction in Own Shares
8th Apr 20137:00 amRNSIssue of Equity
4th Apr 201311:20 amRNSIncrease of Offer Size
2nd Apr 20137:00 amRNSAnnual Financial Report
31st Dec 201211:27 amRNSAllotment of Shares
18th Dec 20123:30 pmRNSResult of General Meeting
22nd Nov 20127:00 amRNSTransaction in Own Shares
19th Nov 201212:26 pmRNSPublication of Prospectus and Circulars re Offer
13th Nov 20122:27 pmRNSInterim Management Statement
26th Oct 20122:06 pmRNSIssue of Equity
1st Oct 201210:03 amRNSStatement re Proposed Joint Fundraising
29th Aug 201211:17 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.